Two Sigma Securities LLC bought a new stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 538 shares of the medical instruments supplier's stock, valued at approximately $658,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new stake in shares of Mettler-Toledo International in the fourth quarter valued at about $33,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Mettler-Toledo International during the 4th quarter valued at approximately $44,000. Blue Trust Inc. boosted its stake in shares of Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 17 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in shares of Mettler-Toledo International in the 4th quarter worth approximately $54,000. Finally, Sound Income Strategies LLC increased its stake in Mettler-Toledo International by 4,500.0% in the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier's stock valued at $56,000 after purchasing an additional 45 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now owns 734 shares in the company, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.
Mettler-Toledo International Price Performance
MTD stock traded down $7.83 during midday trading on Thursday, hitting $1,062.74. The stock had a trading volume of 92,157 shares, compared to its average volume of 144,076. The company's 50-day moving average price is $1,146.09 and its 200 day moving average price is $1,238.73. The firm has a market cap of $22.15 billion, a PE ratio of 26.22, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research firms have commented on MTD. Wells Fargo & Company decreased their target price on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Finally, Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $1,304.25.
Read Our Latest Research Report on Mettler-Toledo International
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Recommended Stories

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.